US Patent Issued to BP InnoMed on Oct. 27 for "LMP1 targeting lanthanide complexes and methods of use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,292, issued on Oct. 27, was assigned to BP InnoMed Ltd. (Hong Kong).

"LMP1 targeting lanthanide complexes and methods of use thereof" was invented by Ka-Leung Wong (Hong Kong), Hong Lok Lung (Hong Kong) and Ho-Fai Chau (Hong Kong).

According to the abstract* released by the U.S. Patent & Trademark Office: "Polypeptides useful for treating and/or imaging latent membrane protein 1 positive cells, such as cells infected with Epstein-Barr virus and Epstein-Barr virus-associated cancers, pharmaceutical compositions comprising the same, and methods of use thereof."

The patent was filed on June 21, 2022, under Application No. 17/807,900.

*For further information, including images, cha...